-
1 Comment
Median Technologies SA is currently in a long term uptrend where the price is trading 24.0% above its 200 day moving average.
From a valuation standpoint, the stock is 94.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.7.
Based on the above factors, Median Technologies SA gets an overall score of 2/5.
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALMDT.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026